Rapid progress in synthetic biology and genetic engineering drives demand for DNA synthesis to design novel biological systems. Research and Development (R&D) Investments: Increasing investments in ...
Mandell's tenure, MaxCyte has achieved significant milestones including its initial public offering on the UK AIM exchange and US Nasdaq Listing, the launch of its flagship ExPERT™ platform, signing ...